Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.
-
LOS ANGELES, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quantum Biopharma Ltd. (“Quantum” or the "Company") (NASDAQ: QNTM) investors of a class action on behalf of investors that...
-
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.
-
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.
-
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.
-
New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026
-
New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026
-
New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026
-
New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026
-
New class action for Quantum Biopharma Ltd (QNTM) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026